Sunday, August 08, 2021 5:30:37 PM
Ministry of Health of Ukraine reserves 300 thousand doses of American medicine for COVID-19 in the form of pills
An American-made coronavirus drug in the form of tablets may appear in Ukraine, 300 thousand doses have already been reserved for Ukrainians. This was announced by the head of the Ministry of Health Viktor Lyashko in a comment to LB.ua.
According to the minister, the innovative drug is already undergoing the third stage of clinical trials - it is expected that it will have a specific effect on COVID-19.
Ukraine has reserved a batch of tablets, but has not paid yet.
The minister did not reveal the name of the drug, but it is known that in March 2021, Pfizer Inc began the first phase of clinical trials of oral antiviral therapy for COVID-19 in the form of tablets in the United States .
The Pfizer CEO said the experimental drug could go on sale by the end of 2021 .
Reuters noted that the Pfizer candidate is the third COVID-19 drug currently being tested. The first was developed by the American company Merck & Co., the second - by the Swiss Roche Holding together with the American Atea Pharmaceuticals.
https://translate.google.com/translate?hl=en&sl=ru&u=https://gordonua.com/news/society/minzdrav-ukrainy-zarezerviroval-300-tys-doz-amerikanskogo-lekarstva-ot-covid-19-v-vide-tabletok-1564153.html&prev=search&pto=aue
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM